Trial
NCT03988205
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
—
Condition
Leukemia, Myeloid, Acute
Intervention
Outpatient Care Model
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-19